ArticleBlood science (Baltimore, Md.)2026

Sequential glofitamab and consolidative ASCT plus CAR-T therapy achieved durable remission in relapsed/refractory DLBCL.

Sijia Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.